The cancer epigenome - components and functional correlates

被引:282
作者
Ting, Angela H.
McGarvey, Kelly M.
Baylin, Stephen B. [1 ]
机构
[1] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
[2] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA
关键词
cancer; cancer stem cell; chromatin modification; DNA methylation; epigenetics;
D O I
10.1101/gad.1464906
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It is increasingly apparent that cancer development not only depends on genetic alterations but on an abnormal cellular memory, or epigenetic changes, which convey heritable gene expression patterns critical for neoplastic initiation and progression. These aberrant epigenetic mechanisms are manifest in both global changes in chromatin packaging and in localized gene promoter changes that influence the transcription of genes important to the cancer process. An exciting emerging theme is that an understanding of stem cell chromatin control of gene expression, including relationships between histone modifications and DNA methylation, may hold a key to understanding the origins of cancer epigenetic changes. This possibility, coupled with the reversible nature of epigenetics, has enormous significance for the prevention and control of cancer.
引用
收藏
页码:3215 / 3231
页数:17
相关论文
共 234 条
[1]   Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31 [J].
Aagaard, L ;
Laible, G ;
Selenko, P ;
Schmid, M ;
Dorn, R ;
Schotta, G ;
Kuhfittig, S ;
Wolf, A ;
Lebersorger, A ;
Singh, PB ;
Reuter, G ;
Jenuwein, T .
EMBO JOURNAL, 1999, 18 (07) :1923-1938
[2]  
Aagaard L, 2000, J CELL SCI, V113, P817
[3]   Increased protein stability causes DNA methyltransferase 1 dysregulation in breast cancer [J].
Agoston, AT ;
Argani, P ;
Yegnasubramanian, S ;
De Marzo, AM ;
Ansari-Lari, MA ;
Hicks, JL ;
Davidson, NE ;
Nelson, WG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (18) :18302-18310
[4]   The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer [J].
Akino, K ;
Toyota, M ;
Suzuki, H ;
Mita, H ;
Sasaki, Y ;
Ohe-Toyota, M ;
Issa, JPJ ;
Hinoda, Y ;
Imai, K ;
Tokino, T .
GASTROENTEROLOGY, 2005, 129 (01) :156-169
[5]   GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer [J].
Akiyama, Y ;
Watkins, N ;
Suzuki, H ;
Jair, KW ;
van Engeland, M ;
Esteller, M ;
Sakai, H ;
Ren, CY ;
Yuasa, Y ;
Herman, JG ;
Baylin, SB .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (23) :8429-8439
[6]   Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene [J].
Bachman, KE ;
Park, BH ;
Rhee, I ;
Rajagopalan, H ;
Herman, JG ;
Baylin, SB ;
Kinzler, KW ;
Vogelstein, B .
CANCER CELL, 2003, 3 (01) :89-95
[7]   Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin [J].
Bachman, KE ;
Rountree, MR ;
Baylin, SB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :32282-32287
[8]   EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast [J].
Bachmann, IM ;
Halvorsen, OJ ;
Collett, K ;
Stefansson, IM ;
Straume, O ;
Haukaas, SA ;
Salvesen, HB ;
Otte, AP ;
Akslen, LA .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (02) :268-273
[9]   Role of DNA 5-methylcytosine transferase in cell transformation by fos [J].
Bakin, AV ;
Curran, T .
SCIENCE, 1999, 283 (5400) :387-390
[10]   Methyl-CpG binding domain protein 2 represses transcription from hypermethylated π-class glutathione S-transferase gene promoters in hepatocellular carcinoma cells [J].
Bakker, J ;
Lin, XH ;
Nelson, WG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (25) :22573-22580